Inhibitory effect of luteinising hormone-releasing hormone analogues on human endometrial cancer in vitro
Authors:
- 1 March 2000
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 150 (1) , 71-78
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Differential Inhibitory Effects on Human Endometrial Carcinoma Cell Growth of Luteinizing Hormone-Releasing Hormone AnaloguesGynecologic Oncology, 1998
- Involvement of Annexin V in Antiproliferative Effects of Gonadotropin-Releasing Hormone Agonists on Human Endometrial Cancer Cell LineGynecologic Oncology, 1997
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Endometrial Neoplasia: Prognostic Significance of Ploidy StatusClinical Obstetrics and Gynecology, 1996
- Presence of Gonadotropin-Releasing Hormone Receptor and Its Messenger Ribonucleic Acid in Endometrial Carcinoma and EndometriumGynecologic Oncology, 1994
- A new treatment for endometrial cancer with gonadotrophin releasing‐hormone analogueBJOG: An International Journal of Obstetrics & Gynaecology, 1991
- Specific low affinity binding sites for gonadotropin-releasing hormone in human endometrial carcinomataEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1991
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptorsBritish Journal of Cancer, 1990
- Gonadotropin-Releasing Hormone (GnRH)-Binding Sites in Human Breast Cancer Cell Lines and Inhibitory Effects of GnRH Antagonists*The Journal of Clinical Endocrinology & Metabolism, 1987